Eledon Pharmaceuticals's total assets for Q1 2025 were $161.31M, a decrease of -9.07% from the previous quarter. ELDN total liabilities were $46.73M for the fiscal quarter, a -21.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.